Virtual-Integrated Twin for Autonomous Lifesaving (VITAL)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-PS-26-26
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AC12
Additional Details
The Defense Advanced Research Projects Agency (DARPA), under the Department of Defense, has issued a solicitation for the Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) program, identified by procurement number DARPA-PS-26-26. This initiative seeks innovative research and development approaches to advance the creation of continuously updating digital twin models of the cardiovascular system. The primary objective is to integrate patient-specific data with biological physics, enabling real-time simulation of potential medical interventions and prediction of their outcomes prior to actual clinical application.
The VITAL program aims to lay the groundwork for causal, prediction-driven decision support tools in medicine. By leveraging mechanistic digital twins, reduced-order models, and data-driven inference, the program intends to define the reliability and actionability of these technologies. The ultimate goal is to transition medical care from a reactive paradigm to one of anticipatory intervention, empowering clinicians—and, in the future, autonomous systems—to evaluate and select optimal treatment strategies before they are implemented. This capability is expected to significantly enhance patient outcomes across a spectrum of clinical scenarios, including acute, chronic, and emergent care settings.
Key requirements for this solicitation include the development of robust, real-time digital twin models that can assimilate diverse patient data streams and accurately simulate physiological responses to interventions. Offerors are expected to address the technical challenges associated with model fidelity, data integration, and predictive reliability. The expected deliverables encompass validated modeling frameworks, demonstration of real-time simulation capabilities, and evidence supporting the clinical utility of the proposed solutions.
This procurement is classified under NAICS code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and carries the Product Service Code AC12. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), specifically the Biological Technologies Office (BTO). The primary point of contact for this opportunity is Dr. Roozbeh Jafari, Program Manager, who can be reached at [email protected].
The solicitation is currently active, with a response deadline set for June 25, 2026. Interested parties are encouraged to review the solicitation and its six attachments, available via the official SAM.gov opportunity listing (Opportunity ID: 3e66d960c0a14d51b236bbcf712d34cf), for detailed submission instructions and program requirements. Contractors with expertise in biomedical modeling, real-time simulation, data integration, and clinical decision support systems are particularly well-suited to contribute to this transformative initiative.
No specific set-aside requirements or special considerations are noted in the provided information. The procurement is structured as a solicitation for research and development services, and all interested, qualified entities are invited to participate.
This opportunity represents a significant and sustained effort to revolutionize medical decision-making through advanced digital twin technology, with the potential for broad and lasting impact on patient care.
Documents6